Author:
Maldonato Benjamin J.,Russell Drake A.,Totah Rheem A.
Abstract
AbstractMethylation of alkyl thiols is a biotransformation pathway designed to reduce thiol reactivity and potential toxicity, yet the gene and protein responsible for human alkyl thiol methyltransferase (TMT) activity remain unknown. Here we demonstrate with a range of experimental approaches using cell lines, in vitro systems, and recombinantly expressed enzyme, that human methyltransferase-like protein 7B (METTL7B) catalyzes the transfer of a methyl group from S-adenosyl-l-methionine (AdoMet) to hydrogen sulfide (H2S) and other exogenous thiol small molecules. METTL7B gene modulation experiments, including knockdown in HepG2 cells and overexpression in HeLa cells, directly alter the methylation of the drug captopril, a historic probe substrate for TMT activity. Furthermore, recombinantly expressed and purified wild-type METTL7B methylates several thiol compounds, including H2S, 7α-thiospironolactone, l-penicillamine, and captopril, in a time- and concentration-dependent manner. Typical for AdoMet-dependent small molecule methyltransferases, S-adenosyl-l-homocysteine (AdoHcy) inhibited METTL7B activity in a competitive fashion. Similarly, mutating a conserved aspartate residue, proposed to anchor AdoMet into the active site, to an alanine (D98A) abolished methylation activity. Endogenous thiols such as glutathione and cysteine, or classic substrates for other known small molecule S-, N-, and O-methyltransferases, were not substrates for METTL7B. Our results confirm, for the first time, that METTL7B, a gene implicated in multiple disease states including rheumatoid arthritis and breast cancer, encodes a protein that methylates small molecule alkyl thiols. Identifying the catalytic function of METTL7B will enable future pharmacological research in disease pathophysiology where altered METTL7B expression and, potentially H2S levels, can disrupt cell growth and redox state.
Funder
National Institute of General Medical Sciences
National Center for Advancing Translational Sciences
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Kröplin, T. & Iven, H. Methylation of 6-mercaptopurine and 6-thioguanine by thiopurine S-methyltransferase A comparison of activity in red blood cell samples of 199 blood donors. Eur. J. Clin. Pharmacol. 56, 343–345 (2000).
2. Lennard, L., Gibson, B. E., Nicole, T. & Lilleyman, J. S. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia. Arch. Dis. Child. 69, 577–579 (1993).
3. Glauser, T. A., Kerremans, A. L. & Weinshilboum, R. M. Human hepatic microsomal thiol methyltransferase. Assay conditions, biochemical properties, and correlation studies. Drug Metab. Dispos. 20, 247–255 (1992).
4. Woodson, L. C. & Weinshilboum, R. M. Human kidney thiopurine methyltransferase purification and biochemical properties. Biochem. Pharmacol. 32, 819–826 (1983).
5. Weinshilboum, R. M., Raymond, F. A. & Pazmiño, P. A. Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin. Chim. Acta 85, 323–333 (1978).
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献